FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205479262> ?p ?o ?g. }

• W4205479262 abstract "Background: RYR is a commonly used lipid-lowering dietary supplements in Asian and European countries, showing considerable benefits and low toxicity. This quantitative study aims to present high-quality evidence regarding the efficacy and safety of RYR in treating hyperlipidemia, in order to promote its clinical application. Methods: PubMed, embase, and Cochrane Central Register of Controlled Trials databases were systematically searched, and high-quality randomized controlled trials comparing RYR with non-RYR interventions were included. RevMan5.3 software was used to conduct the meta-analysis. Results: A total of 1,012 individuals participated in this study (481 in the experimental and 531 in the control group). In comparison to statins, RYR was more effective in lowering TG (MD, -19.90; 95% CI, -32.22 to -7.58; p = 0.002), comparable in lowering LDL-C and elevating HDL-C, and less effective in lowering TC (MD, 12.24; 95% CI, 2.19 to 22.29; p = 0.02). Compared with nutraceutical, RYR significantly reduced TC (MD, -17.80; 95% CI, -27.12 to -8.48; p = 0.0002) and LDL-C (MD, -14.40; 95% CI, -22.71 to -6.09; p = 0.0007), and elevated HDL-C (MD, 7.60; 95% CI, 4.33 to 10.87; p < 0.00001). Moreover, RYR effectively synergized nutraceutical to further reduce TC (MD, -31.10; 95% CI, -38.83 to -23.36; p < 0.00001), LDL-C (MD, -27.91; 95% CI, -36.58 to -19.24; p < 0.00001), and TG (MD, -26.32; 95% CI, -34.05 to -18.59; p < 0.00001). Additionally, RYR significantly reduced apoB (MD, -27.98; 95% CI, -35.51 to -20.45; p < 0.00001) and, whether alone or in combination, did not increase the risk of adverse events in patients with hyperlipidemia. Conclusion: RYR at 200-4800 mg daily appears to be a safe and effective treatment for hyperlipidemia, effectively regulating blood lipid levels with an exceptional impact on TG. Looking forward, high-quality clinical trials with longer observation periods are required to evaluate the efficacy and safety of RYR as a long-term medication. Systematic Review Registration: (https://www.crd.york.ac.uk/PROSPERO/), identifier (CRD4202128450)." @default.
• W4205479262 created "2022-01-25" @default.
• W4205479262 creator A5012131719 @default.
• W4205479262 creator A5015195367 @default.
• W4205479262 creator A5018823994 @default.
• W4205479262 creator A5026323105 @default.
• W4205479262 creator A5047513637 @default.
• W4205479262 creator A5058981281 @default.
• W4205479262 creator A5063347622 @default.
• W4205479262 creator A5069913342 @default.
• W4205479262 creator A5070880721 @default.
• W4205479262 creator A5090092305 @default.
• W4205479262 date "2022-01-17" @default.
• W4205479262 modified "2023-09-27" @default.
• W4205479262 title "Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials" @default.
• W4205479262 cites W1502524639 @default.
• W4205479262 cites W1523191676 @default.
• W4205479262 cites W1598602811 @default.
• W4205479262 cites W1965048958 @default.
• W4205479262 cites W1973557710 @default.
• W4205479262 cites W1983384986 @default.
• W4205479262 cites W1991952379 @default.
• W4205479262 cites W2010033213 @default.
• W4205479262 cites W2018227915 @default.
• W4205479262 cites W2020043339 @default.
• W4205479262 cites W2029876428 @default.
• W4205479262 cites W2029932977 @default.
• W4205479262 cites W2031185570 @default.
• W4205479262 cites W2047499561 @default.
• W4205479262 cites W2050915560 @default.
• W4205479262 cites W2051315228 @default.
• W4205479262 cites W2057135977 @default.
• W4205479262 cites W2063156365 @default.
• W4205479262 cites W2064006730 @default.
• W4205479262 cites W2078603028 @default.
• W4205479262 cites W2085144467 @default.
• W4205479262 cites W2100323547 @default.
• W4205479262 cites W2111103048 @default.
• W4205479262 cites W2116584510 @default.
• W4205479262 cites W2117274684 @default.
• W4205479262 cites W2123124749 @default.
• W4205479262 cites W2134159541 @default.
• W4205479262 cites W2139401878 @default.
• W4205479262 cites W2165921191 @default.
• W4205479262 cites W2167949935 @default.
• W4205479262 cites W2168356010 @default.
• W4205479262 cites W2188121586 @default.
• W4205479262 cites W2193096301 @default.
• W4205479262 cites W2270669984 @default.
• W4205479262 cites W2294176438 @default.
• W4205479262 cites W2407578670 @default.
• W4205479262 cites W2479129552 @default.
• W4205479262 cites W2528196902 @default.
• W4205479262 cites W2795540840 @default.
• W4205479262 cites W2807970930 @default.
• W4205479262 cites W2910151637 @default.
• W4205479262 cites W2919994166 @default.
• W4205479262 cites W2991205756 @default.
• W4205479262 cites W2992668033 @default.
• W4205479262 cites W3005804833 @default.
• W4205479262 cites W3117454602 @default.
• W4205479262 cites W3118615836 @default.
• W4205479262 cites W3126288346 @default.
• W4205479262 cites W3134759588 @default.
• W4205479262 cites W4250166675 @default.
• W4205479262 doi "https://doi.org/10.3389/fphar.2021.819482" @default.
• W4205479262 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35111069" @default.
• W4205479262 hasPublicationYear "2022" @default.
• W4205479262 type Work @default.
• W4205479262 citedByCount "6" @default.
• W4205479262 countsByYear W42054792622022 @default.
• W4205479262 countsByYear W42054792622023 @default.
• W4205479262 crossrefType "journal-article" @default.
• W4205479262 hasAuthorship W4205479262A5012131719 @default.
• W4205479262 hasAuthorship W4205479262A5015195367 @default.
• W4205479262 hasAuthorship W4205479262A5018823994 @default.
• W4205479262 hasAuthorship W4205479262A5026323105 @default.
• W4205479262 hasAuthorship W4205479262A5047513637 @default.
• W4205479262 hasAuthorship W4205479262A5058981281 @default.
• W4205479262 hasAuthorship W4205479262A5063347622 @default.
• W4205479262 hasAuthorship W4205479262A5069913342 @default.
• W4205479262 hasAuthorship W4205479262A5070880721 @default.
• W4205479262 hasAuthorship W4205479262A5090092305 @default.
• W4205479262 hasBestOaLocation W42054792621 @default.
• W4205479262 hasConcept C126322002 @default.
• W4205479262 hasConcept C134018914 @default.
• W4205479262 hasConcept C142724271 @default.
• W4205479262 hasConcept C168563851 @default.
• W4205479262 hasConcept C17857428 @default.
• W4205479262 hasConcept C204787440 @default.
• W4205479262 hasConcept C2778163477 @default.
• W4205479262 hasConcept C2778223628 @default.
• W4205479262 hasConcept C2778270857 @default.
• W4205479262 hasConcept C2779091943 @default.
• W4205479262 hasConcept C555293320 @default.
• W4205479262 hasConcept C71924100 @default.
• W4205479262 hasConcept C90924648 @default.
• W4205479262 hasConcept C95190672 @default.
• W4205479262 hasConceptScore W4205479262C126322002 @default.
• W4205479262 hasConceptScore W4205479262C134018914 @default.

• next